Clinical trial
APixaban Versus PhenpRocoumon: Oral AntiCoagulation Plus Antiplatelet tHerapy in Patients With Acute Coronary Syndrome and Atrial Fibrillation
NCT02789917 is registered in ClinicalTrials.gov with LMU Klinikum as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- APixaban Versus PhenpRocoumon: Oral AntiCoagulation Plus Antiplatelet tHerapy in Patients With Acute Coronary Syndrome and Atrial Fibrillation
- Lead sponsor
- LMU Klinikum
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2016
- Completion date
- August 31, 2020
- Enrollment
- 403 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.